Disparities in patient share and characteristics between disease-modifying therapy-treated and -untreated people with multiple sclerosis in Germany: a claims data analysis from 2017 to 2022

Authors

Nils-Henning Neß (ORCID: https://orcid.org/0000-0002-2365-8855)
Peter Flachenecker
Ann-Sophie Stratil (ORCID: https://orcid.org/0000-0002-8977-6731)
Benjamin Friedrich (ORCID: https://orcid.org/0000-0002-2198-9925)
Ido Wolf (ORCID: https://orcid.org/0000-0001-9319-7612)
Antonios Bayas (ORCID: https://orcid.org/0000-0002-7418-9040)
Steffeni Papukchieva (ORCID: https://orcid.org/0000-0002-9849-8403)

Institutions

University of Augsburg (DE)
Hexal (Germany) (DE)
Neurologisches Rehabilitationszentrum Quellenhof Bad Wildbad (DE)

Publication Details

Journal: Frontiers in Neurology
Published: 2025-04-15
DOI: https://doi.org/10.3389/fneur.2025.1561810
Primary Topic: Multiple Sclerosis Research Studies
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Bristol-Myers Squibb
Sanofi
Biogen
Teva Pharmaceutical Industries
Alexion Pharmaceuticals
Celgene
Argenx
Coloplast
Grifols
Cilag

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Disparities in patient share and characteristics between disease-modifying therapy-treated and -untreated people with multiple sclerosis in Germany: a claims data analysis from 2017 to 2022

Nils-Henning Neß, Peter Flachenecker, Ann-Sophie Stratil, Benjamin Friedrich et al.

Apr 15, 2025

1 links

Frontiers in Neurology

Multiple Sclerosis Research Studies

article

Disparities in patient share and characteristics between disease-modifying therapy-treated and -untreated people with multiple sclerosis in Germany: a claims data analysis from 2017 to 2022

Nils-Henning Neß, Peter Flachenecker, Ann-Sophie Stratil, Benjamin Friedrich, Ido Wolf, Antonios Bayas, Steffeni Papukchieva

April 15, 2025article en

Abstract

No abstract available for this paper.

Frontiers in NeurologyVol. 16

University of Augsburg (DE), Hexal (Germany) (DE), Neurologisches Rehabilitationszentrum Quellenhof Bad Wildbad (DE)

Bristol-Myers Squibb, Sanofi, Biogen, Teva Pharmaceutical Industries, Alexion Pharmaceuticals, Celgene, Argenx, Coloplast, Grifols, Cilag

Openalex Percentile: Top 89%

Multiple Sclerosis Research Studies

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.